NANOTECHNOLOGY IN TUBERCULOSIS
-
Upload
aniket-vaidya -
Category
Science
-
view
451 -
download
0
Transcript of NANOTECHNOLOGY IN TUBERCULOSIS
![Page 1: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/1.jpg)
Potential of Nanotechnology as a delivery platform against
Tuberculosis
Guided by:Dr. K.N. Gujar M.Pharm, Ph.D
Co-guided by: DR. M.S. GAMBHIRE
M. Pharm, Ph.D
Presented by:Mr. Aniket A. Vaidya
M. Pharm 1st sem.Pharmaceutics
Roll no. 522
Sinhgad College Of Pharmacy, Vadgaon (BK), Pune-41
A seminar on
Date of seminar: 29 OCT. 2015
1 Aniket A. Vaidya
![Page 2: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/2.jpg)
05/03/2023Aniket A. Vaidya2
Introduction:Tuberculosis is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) .mycobacterial species : (M. bovis, M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together comprise what is known as the M. tuberculosis complex. M. tuberculosis organisms are also called tubercle bacilli.
Jung Kwon Oha et al , The development of microgels/nanogels for drug delivery applications, Progress In Polymer Science 33 (2008) 448–477
Mycobacterium tuberculosis
![Page 3: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/3.jpg)
Types of Tuberculosis
Ganga Srinivas et al.” Polymer Based Microgels/Nanogels: Development and Application In Drug Delivery” Am. J. PharmTech Res. 2014; 4(1) ISSN: 2249-3387
05/03/2023Aniket A. Vaidya3
![Page 4: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/4.jpg)
4
.
Symptoms and Sings of Tuberculosis
Ganga Srinivas et al.” Polymer Based Microgels/Nanogels: Development and Application In Drug Delivery” American Journal of Pharma Tech .Research. 2014; 4(1) ISSN: 2249-3387
![Page 5: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/5.jpg)
05/03/2023Aniket A. Vaidya
Pathogenesis of TB
Jung Kwon Oha et al , The development of microgels/nanogels for drug delivery applications, Prog. Polym. Sci. 33 (2008) 448–477
5
![Page 6: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/6.jpg)
![Page 7: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/7.jpg)
NANOTECHNOLOGY
7
![Page 8: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/8.jpg)
8
Nanotechnology is the study of extremely small structures, having size of 0.1 to 100 nm
![Page 9: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/9.jpg)
05/03/2023Aniket A. Vaidya
Routes and mechanisms of particle transport across epithelia
9
![Page 10: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/10.jpg)
Nanoparticle transport
Jung Kwon Oha, Ray Drumright et al , “The development of microgels/nanogels for drug delivery applications”, Progress in Polymer Science. 33 (2008) 448–477.
10
![Page 11: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/11.jpg)
Objective
Jung Kwon Oha, Ray Drumright et al , “The development of microgels/nanogels for drug delivery applications”, Progress in Polymer Science. 33 (2008) 448–477.
Fig:Reverse micellar method for the preparation of nanogels.
11
![Page 12: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/12.jpg)
Jung Kwon Oha, Ray Drumright et al , “The development of microgels/nanogels for drug delivery applications”, Progress in Polymer Science. 33 (2008) 448–477.
05/03/2023Aniket A. Vaidya12
Encapsulation of ATDs into multifunctional polymeric nanoparticles.
![Page 13: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/13.jpg)
Encapsulation of all four drugs
Sanjida Sharmin et al, “ An Overview of Nanogel Drug Delivery System”. Journal of Applied pharmaceutical science vol.3 september 2013.
05/03/2023Aniket A. Vaidya13
PLGA Nanocapsule
Encapsulation of pre-formed drug-loaded micelle-like containers
![Page 14: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/14.jpg)
Pharmaceutical consideration
1. Drug loading:
a. Post formation loadingb . In situ loading
2. Covalent conjugation3. Self assembly
Ganga Srinivas et al.” Polymer Based Microgels/Nanogels: Development and Application In Drug Delivery” American Journal of Pharma Tech .Research. 2014; 4(1) ISSN: 2249-3387
14
![Page 15: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/15.jpg)
PROPERTIES
• Biocompatibility and degradability
• Swelling property
• Higher drug loading capacity
• Particle size
• Solubility
• Electromobility
• Colloidal stability
• Others
Sanjida Sharmin et al, “ An Overview of Nanogel Drug Delivery System”. Journal of Applied pharmaceutical science vol.3 september 2013.
15
![Page 16: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/16.jpg)
CASE STUDY : 1
05/03/2023Aniket A. Vaidya16
![Page 17: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/17.jpg)
MaterialsChitosanPolylacticacidDichloromethanePolyethylene
glycolGelatinPoly(ethylene
oxide)Phosphate buffer
salineRifampicin
17
Methods
Preparation of CS-PLA nanoparticles
Preparation of Rifampicin loaded CS-PLA nanoparticles
![Page 18: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/18.jpg)
Method of preparation
18
Aq. Solution of drug + polymer solution
w/o emulsion poured into 10ml of 1% acetic acid solution contain 60mg of CS & 200mg of PEO
Add water , nanoparticles ppt then cooled at 10oC
Mixture sonicate for 60 min Form emulsion
Nanoparticles evaoporated by rotary evaporator
Then the above mentioned procedure was followed and added PEG and gelatin.
![Page 19: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/19.jpg)
05/03/2023Aniket A. Vaidya
The prepared nanoparticles were named as
19
chitosan–polylactic acid encapsulated rifampicin (CS–PLA–RIF),
chitosan–polylactic acid–polyethyleneglycol encapsulated rifampicin (CS–PLA–RIF–PEG)
and chitosan–polylactic acid–polyethylene glycol–gelatin encapsulated rifampicin (CS–PLA–RIF–PEG–G).
![Page 20: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/20.jpg)
Results :
20
Fig.The zeta pontential values of CS–PLA–RIF, CS–PLA–RIF–PEG,CS–PLA–RIF–PEG–G with various concentrations.
Particle size and zeta potential of the prepared nanoparticles
![Page 21: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/21.jpg)
05/03/2023
Surface morphology
Aniket A. Vaidya21
Fig. 2. SEM images of rifampicin (a), CS–PLA–RIF (b), CS–PLA–RIF–PEG (c) and CS–PLA–RIF–PEG–G (d).
![Page 22: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/22.jpg)
05/03/2023Aniket A. Vaidya22
FTIR Spectra
Fig. 3. FTIR spectra of CS–PLA–RIF, CS–PLA–RIF–PEG and CS–PLA–RIF–PEG–G (a),and 10–50% of RIF encapsulated CS–PLA–RIF–PEG–G (b).
![Page 23: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/23.jpg)
05/03/2023Aniket A. Vaidya23
In vitro studies
Fig. 4. In vitro analysis of rifampicin prepared nanoparticles.
![Page 24: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/24.jpg)
05/03/2023Aniket A. Vaidya24
.
Cell inhibition studies
The relative cell viability of RIF, CS–PLA–RIF, CS–PLA–RIF–PEG and CS–PLA–RIF–PEG–G nanoparticles
![Page 25: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/25.jpg)
Conclusions:In this study, the effectiveness of SLN gel for dermal
delivery of MLX was investigated.They seemed appropriate for sustained and controlled
release due to the possible formation of a drug depot in the skin. Thus,
It can be concluded that SLNs offer a better option for the delivery of NSAIDs via skin in order to avoid gastrointestinal side effects which occur after oral administration.
25
![Page 26: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/26.jpg)
CASE STUDY : 2
05/03/2023Aniket A. Vaidya26
![Page 27: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/27.jpg)
Materials Poly(lactic-co-glycolic acid) (PLGA)(lactic acid:glycolic acid ratio=75:25) Nanoparticles-containing mannitol (MAN) Rifampicin (RFP) Rat normal alveolar macrophage cells Coumarin 6 Indomycin green (ICG)
05/03/2023Aniket A. Vaidya27
![Page 28: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/28.jpg)
Methods Preparation of RFP-PLGA nanoparticle-containing MAN
microshperes using a four-fluid nozzle spray drier
Preparation of RFP-PLGA microspheres using a
traditional two-fluid spray drier
05/03/2023Aniket A. Vaidya28
![Page 29: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/29.jpg)
Preparation of RFP–PLGA nanoparticles-containing MAN microspheres using a four-fluid nozzle spray drier (model MDL-050)
RFP:PLGA (1:10)
dissolved at 1.67%(w/v) in a 2:1 solution of acetone/methanol
MAN
dissolvedIn water at 16.7% (w/v)
RFP–PLGA:MAN composition ratioof 1:10 (w/w)
29The RFP/MAN micro particles were prepared in the same manner
Spray drying conditions:inlet temperature, 60 °C; supply rate for coumarin–PLGA or MANsolutions, 5 mL/min; spray rate for air, 30 L/min; spray air pressure,0.78 MPa.
![Page 30: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/30.jpg)
05/03/2023Aniket A. Vaidya
Schematic diagram of the four-fluid nozzle
30
![Page 31: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/31.jpg)
Preparation of RFP–PLGA microspheres using a traditional two-fluidspray drier (Pulvis mini-spray GB22)
RFP:PLGA ratio
was 1:10RFP and PLGA were dissolved at 4.4%(w/v) in a 2:1 solution of acetone/methanol
Water was added at 5%v/v in the spray solution
05/03/2023Aniket A. Vaidya31
Spray drying conditions: inlet temperature, 50 °C; supply rate for solution,5mL/min; spray air pressure, 0.29 MPa
![Page 32: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/32.jpg)
Result
32
Fig. 1 SEM photographs and images of the RFP/PLGA microspheres, the (RFP/PLGA)/MAN microspheres, and the RFP/PLGA nanoparticles dispersed in MAN.
![Page 33: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/33.jpg)
In-vitro studies
Fig. 2. In vitro uptake percentage of coumarin by alveolar macrophage cells afteradministration of the coumarin/PLGA microspheres and the (coumarin/PLGA)/MANmicrospheres. Dose: 1 μg of coumarin/well. Each point represents the mean±S.D. (n=3).
05/03/2023Aniket A. Vaidya33
Fig. 3. Aerosol performances of RFP/PLGA microspheres and (RFP/PLGA)/MAN microspheres.Each point represents the mean±S.D. (n=3). □, RFP/PLGA microspheres;■, (RFP/PLGA)/MAN microspheres
![Page 34: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/34.jpg)
In-vivo drug release studies
Fig. 5. In vivo uptake of RFP by alveolar macrophages in lungs of rats after administrationof RFP/MAN, RFP/PLGA,and(RFP/PLGA)/MAN microspheres. Dose: 150 μg/kg of RFP.Each point represents the mean±S.E. (n=6).
05/03/2023Aniket A. Vaidya34
Fig 6 In vivo fluorescent images of lungs of rats after administration of ICG/PLGA and (ICG/PLGA)/MAN microspheres
![Page 35: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/35.jpg)
Conclusion
pH responsive chitin-PCL CNGs were developed and a hydrophilic drug,
Dox. was effectively loaded on to the Chitin-PCLCNGs
DTA confirmed the thermal stability of Dox-Chitin-PCL CNGs. swelling
and drug release at acidic pH.
In addition the Dox-Chitin-PCL CNGs shows significant cytotoxic effects
against A549 (lung cancer) cells. These studies prove the potential of
Chitin-PCL CNGs as a promising drug delivery vehicle for lung cancer.
05/03/2023Aniket A. Vaidya
35
![Page 36: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/36.jpg)
Conclusion:
36
Nanogels are promising and innovative drug delivery system . Nanogels appear to be excellent candidates for brain
delivery .This will be especially important for the targeting of cancer cells.
![Page 37: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/37.jpg)
REFERENCES
1. Jung Kwon Oha, Ray Drumright et al , “The development of microgels/nanogels for drug delivery applications”, Progress in Polymer Science. 33 (2008) 448–477.
2. Sanjida Sharmin et al, “ An Overview of Nanogel Drug Delivery System”. Journal of Applied pharmaceutical science vol.3 september 2013.
3. L.Divya1, V. Ravichandiran et al , “Nanogels – as A Drug Delivery Carrier” , Indo American journal of pharmaceutical research.
4. Reuben T. Chacko, Judy Ventura et al, “Polymer nanogels: A versatile nanoscopic drug delivery platform” , Advanced Drug Delivery Reviews 64 (2012) 836–851.
5. Reuben T. Chacko, Judy Ventura, Jiaming Zhuang, S. Thayumanavan , “Polymer nanogels: A versatile nanoscopic drug delivery platform”, Advanced Drug Delivery Reviews 64 (2012) 836–851.
05/03/2023Aniket A. Vaidya37
![Page 38: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/38.jpg)
6. Dhawal dorwal , “Nanogels as novel versatile pharmaceuticals” , International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 3, 2012
7. Ganga Srinivas, Pooja Ramnathkar, “Polymer Based Microgels/Nanogels: Development and Application In Drug Delivery”, Am. J. PharmTech Res. 2014; 4(1) ISSN: 2249-3387.
8. Farhana Sultana S. Khuranaa, P.M.S. Bedia, N.K. Jainb, “Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam”, Chemistry and Physics of Lipids (2013).
9. T.R. Arunraj, N. Sanoj Rejinold, N. Ashwin Kumar, R. Jayakumar, “ Doxorubicin-chitin-poly (caprolactone) composite nanogel for drug delivery’’ ,International Journal of Biological Macromolecules 62 (2013) 35– 43.
38
![Page 39: NANOTECHNOLOGY IN TUBERCULOSIS](https://reader036.fdocuments.net/reader036/viewer/2022081605/5872c7261a28ab0c718b66d9/html5/thumbnails/39.jpg)
05/03/2023Aniket A. Vaidya39